SCHEMBL21394901

SCHEMBL21394901

CC(C)(C)OC(=O)Nc1ncc(C(O)c2cc(F)ccc2F)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 3/20 0.41
CDK2 P24941 3/20 0.41
CDK5 Q00535 3/20 0.41
P2RY2 P41231 1/20 0.38
GCK P35557 2/20 0.37
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRA4 P48169 1/20 0.36
GABRA6 Q16445 1/20 0.36
FFAR2 O15552 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
LCK P06239 2/20 0.35
SYK P43405 1/20 0.35
S1PR3 Q99500 1/20 0.35
RORC P51449 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29353674 1.00 CCNE1 (0.41) CCNE1CDK2CDK5P2RY2GCK
SCHEMBL29358389 0.91 CCNE1 (0.41) CCNE1CDK2CDK5P2RY2GCK
SCHEMBL21395245 0.91 CCNE1 (0.41) CCNE1CDK2CDK5P2RY2GCK
SCHEMBL21394896 0.83 P2RY2 (0.42) CCNE1CDK2CDK5P2RY2FFAR2
SCHEMBL21384235 0.83 CCNE1 (0.40) CCNE1CDK2CDK5GCK
SCHEMBL29356596 0.83 SCD (0.45) CCNE1CDK2CDK5P2RY2LCK
SCHEMBL21394898 0.83 SCD (0.45) CCNE1CDK2CDK5P2RY2LCK
SCHEMBL21395247 0.82 PSEN1 (0.48) CCNE1CDK2CDK5P2RY2CA1
SCHEMBL29358368 0.81 L3MBTL1 (0.45)
SCHEMBL19003723 0.81 CCNE1 (0.42) CCNE1CDK2CDK5P2RY2FFAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114845709-A MRGPRX2 antagonists for use in treating inflammatory disorders 德米拉公司 2022-08-02 CN disclosed
WO-2020198026-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed
WO-2019183587-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed